Euroapi Company Header Euroapi Company Header

X

Find the latest news about Lykos Therapeutics aggregated by PharmaCompass.com.

  • Webinars & Exhibitions

PharmaCompass
Send me more info on How To Grow My Bussiness Digitally?
Lykos Therapeutics
United_States_of_America Flag
Country
Country
U.S.A
Address
Address
San Jose, California 95117
Telephone
Telephone

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

https://endpts.com/lykos-takes-another-hit-as-icer-lays-out-insufficient-evidence-for-mdma-based-treatment/

ENDPOINTS
27 Jun 2024

https://www.fiercebiotech.com/biotech/mdma-debate-spreading-beyond-biotech-lykos-ceo-tries-dispel-efficacy-safety-concerns

Annalee Armstrong FIERCE BIOTECH
13 Jun 2024

https://www.biopharmadive.com/news/mdma-psychedelic-drug-development-hurdles-fda-panel-vote/718290/

Jacob Bell BIOPHARMADIVE
07 Jun 2024

https://www.reuters.com/business/healthcare-pharmaceuticals/fda-panel-review-psychedelic-drug-mdma-first-time-2024-06-04/

REUTERS
05 Jun 2024

https://www.prnewswire.com/news-releases/lykos-therapeutics-provides-update-on-fda-advisory-committee-meeting-for-investigational-mdma-assisted-therapy-for-ptsd-302163950.html

PR NEWSWIRE
04 Jun 2024

https://firstwordpharma.com/story/5862576

ENDPTS
01 Jun 2024

https://endpts.com/icer-raises-questions-over-lykos-mdma-studies-as-adcomm-looms/

ENDPTS
15 May 2024

https://www.reuters.com/business/healthcare-pharmaceuticals/us-fda-panel-discuss-first-psychedelic-assisted-ptsd-treatment-next-month-2024-05-06/

REUTERS
07 May 2024

https://www.fiercebiotech.com/biotech/fda-advisers-weigh-first-psychedelic-therapy-early-june

Max Bayer FIERCE BIOTECH
07 May 2024

https://endpts.com/psychedelic-assisted-drug-developer-maps-pbc-nabs-100m-renames-to-lykos-therapeutics/

Kyle LaHucik ENDPTS
05 Jan 2024
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty
Post Enquiry
POST ENQUIRY